STAT Plus: FDA finalizes penalties for clinical trial sponsors that don’t share data, but critics say they fall short
“This seems to severely limit when and where the FDA plans to actually try and enforce the law,” said Nicholas DeVito of the University of Oxford's EBM Lab.
No hay comentarios:
Publicar un comentario